Ephrin A2
      
Ephrin-A2 is a protein that in humans is encoded by the EFNA2 gene.[3]
This gene encodes a member of the ephrin family. The protein is composed of a signal sequence, a receptor-binding region, a spacer region, and a hydrophobic region. The EPH and EPH-related receptors comprise the largest subfamily of receptor protein-tyrosine kinases and have been implicated in mediating developmental events, particularly in the nervous system. Based on their structures and sequence relationships, ephrins are divided into the ephrin-A (EFNA) class, which are anchored to the membrane by a glycosylphosphatidylinositol linkage, and the ephrin-B (EFNB) class, which are transmembrane proteins. Posttranslational modifications determine whether this protein localizes to the nucleus or the cytoplasm.[3]
References
Further reading
- Flanagan JG, Vanderhaeghen P (1998). "The ephrins and Eph receptors in neural development". Annu. Rev. Neurosci. 21: 309–45. doi:10.1146/annurev.neuro.21.1.309. PMID 9530499. 
- Zhou R (1998). "The Eph family receptors and ligands". Pharmacol. Ther. 77 (3): 151–81. doi:10.1016/S0163-7258(97)00112-5. PMID 9576626. 
- Holder N, Klein R (1999). "Eph receptors and ephrins: effectors of morphogenesis". Development. 126 (10): 2033–44. PMID 10207129. 
- Wilkinson DG (2000). "Eph receptors and ephrins: regulators of guidance and assembly". Int. Rev. Cytol. International Review of Cytology. 196: 177–244. doi:10.1016/S0074-7696(00)96005-4. ISBN 978-0-12-364600-2. PMID 10730216. 
- Xu Q, Mellitzer G, Wilkinson DG (2001). "Roles of Eph receptors and ephrins in segmental patterning". Philos. Trans. R. Soc. Lond., B, Biol. Sci. 355 (1399): 993–1002. doi:10.1098/rstb.2000.0635. PMC 1692797 . PMID 11128993. . PMID 11128993.
- Wilkinson DG (2001). "Multiple roles of EPH receptors and ephrins in neural development". Nat. Rev. Neurosci. 2 (3): 155–64. doi:10.1038/35058515. PMID 11256076. 
- Gale NW, Holland SJ, Valenzuela DM,  et al. (1996). "Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis". Neuron. 17 (1): 9–19. doi:10.1016/S0896-6273(00)80276-7. PMID 8755474. 
- Ephnomenclaturecommittee (1997). "Unified nomenclature for Eph family receptors and their ligands, the ephrins. Eph Nomenclature Committee". Cell. 90 (3): 403–4. doi:10.1016/S0092-8674(00)80500-0. PMID 9267020. 
- Cerretti DP, Nelson N (1998). "Characterization of the genes for mouse LERK-3/Ephrin-A3 (Epl3), mouse LERK-4/Ephrin-A4 (Epl4), and human LERK-6/Ephrin-A2 (EPLG6): conservation of intron/exon structure". Genomics. 47 (1): 131–5. doi:10.1006/geno.1997.5088. PMID 9465306. 
- Ciossek T, Monschau B, Kremoser C,  et al. (1998). "Eph receptor-ligand interactions are necessary for guidance of retinal ganglion cell axons in vitro". Eur. J. Neurosci. 10 (5): 1574–80. doi:10.1046/j.1460-9568.1998.00180.x. PMID 9751130. 
- Aasheim HC, Pedeutour F, Grosgeorge J, Logtenberg T (1998). "Cloning, chromosal mapping, and tissue expression of the gene encoding the human Eph-family kinase ligand ephrin-A2". Biochem. Biophys. Res. Commun. 252 (2): 378–82. doi:10.1006/bbrc.1998.9618. PMID 9826538. 
- Gerlai R, Shinsky N, Shih A,  et al. (1999). "Regulation of learning by EphA receptors: a protein targeting study". J. Neurosci. 19 (21): 9538–49. PMID 10531456. 
- Hattori M, Osterfield M, Flanagan JG (2000). "Regulated cleavage of a contact-mediated axon repellent". Science. 289 (5483): 1360–5. doi:10.1126/science.289.5483.1360. PMID 10958785. 
- Rodger J, Lindsey KA, Leaver SG,  et al. (2002). "Expression of ephrin-A2 in the superior colliculus and EphA5 in the retina following optic nerve section in adult rat". Eur. J. Neurosci. 14 (12): 1929–36. doi:10.1046/j.0953-816x.2001.01822.x. PMID 11860487. 
 
|  | 
|---|
|  | 
| Angiopoietin |  | 
|---|
|  | 
| CNTF |  | 
|---|
|  | 
| EGF (ErbB) |  | 
|---|
|  | 
| FGF | |  |  | 
|---|
 |  |  |  | 
 Agonists: Ersofermin FGF (1, 2 (bFGF), 3, 4, 5, 6, 7 (KGF), 8, 9, 10 (KGF2), 17, 18, 22) Palifermin Repifermin Sprifermin Trafermin
  Antibodies: Aprutumab Aprutumab ixadotin
 | 
|---|
 |  |  |  |  | 
|---|
 |  |  |  |  | 
|---|
 |  |  | Unsorted |  | 
|---|
 | 
|---|
|  | 
| HGF (c-Met) |  | 
|---|
|  | 
| IGF | |  | 
 Kinase inhibitors: Linsitinib NVP-ADW742 NVP-AEW541 OSl-906
 | 
|---|
 |  |  |  |  | 
|---|
 |  |  | Others | 
 Cleavage products/derivatives with unknown target: Glypromate (GPE, (1-3)IGF-1) Trofinetide
 | 
|---|
 | 
|---|
|  | 
| LNGF |  | 
|---|
|  | 
| PDGF |  | 
|---|
|  | 
| RET (GFL) | |  |  | 
|---|
 |  |  |  |  | 
|---|
 |  |  |  |  | 
|---|
 |  |  |  |  | 
|---|
 |  |  | Unsorted | 
 Kinase inhibitors: Agerafenib
 | 
|---|
 | 
|---|
|  | 
| SCF (c-Kit) |  | 
|---|
|  | 
| TGFβ |  | 
|---|
|  | 
| Trk | |  |  | 
|---|
 |  |  |  | 
 Agonists: 3,7-DHF 3,7,8,2'-THF 4'-DMA-7,8-DHF 7,3'-DHF 7,8-DHF 7,8,2'-THF 7,8,3'-THF Amitriptyline BDNF Deoxygedunin Diosmetin HIOC LM22A-4 N-Acetylserotonin NT-3 NT-4 Norwogonin (5,7,8-THF) R7 TDP6
 | 
|---|
 |  |  |  |  | 
|---|
 | 
|---|
|  | 
| VEGF |  | 
|---|
|  | 
| Others | 
 Additional growth factors: Adrenomedullin Colony-stimulating factors (see here instead) Connective tissue growth factor (CTGF) Ephrins (A1, A2, A3, A4, A5, B1, B2, B3) Erythropoietin (see here instead) Glucose-6-phosphate isomerase (GPI; PGI, PHI, AMF) Glia maturation factor (GMF) Hepatoma-derived growth factor (HDGF) Interleukins/T-cell growth factors (see here instead) Leukemia inhibitory factor (LIF) Macrophage-stimulating protein (MSP; HLP, HGFLP) Midkine (NEGF2) Migration-stimulating factor (MSF; PRG4) Oncomodulin Pituitary adenylate cyclase-activating peptide (PACAP) Pleiotrophin Renalase Thrombopoietin (see here instead) Wnt signaling proteins
  Additional growth factor receptor modulators: Cerebrolysin (neurotrophin mixture)
 | 
|---|
|  | 
| 
 See also: Peptide receptor modulators Cytokine receptor modulators
 |